ArticleThe Journal of investigative dermatology2023

EGFR Signaling Is Overactive in Pachyonychia Congenita: Effective Treatment with Oral Erlotinib.

Justine Basset et al.PubMed ↗Publisher ↗

No numbers read from the abstract.